Aethoxysklerol (Lauromacrogol 400)

Aethoxysklerol is a pharmaceutical preparation containing Lauromacrogol 400, used for intravenous applications. It is manufactured by Chemische Fabrik Kreussler & Co. Gmbh in the EU. This product is designed for specific medical uses, including sclerotherapy.

Aethoxysklerol, containing Lauromacrogol 400, is primarily used for sclerotherapy, a procedure to treat varicose veins and other vascular conditions. It works by irritating the inner lining of blood vessels, causing them to collapse and close off. This can help redirect blood flow to healthier veins. The primary use of Aethoxysklerol is to address issues related to abnormal blood vessels.

When administered intravenously, Aethoxysklerol can cause the targeted blood vessels to harden and close. This process helps to improve blood circulation by redirecting it through healthier veins. Common effects may include localized discomfort or swelling at the injection site, which typically subsides over time.

Aethoxysklerol should be handled with care and administered by healthcare professionals. It is important to follow proper medical guidelines to ensure safe and effective use. Patients should inform their healthcare provider about any allergies or medical conditions before treatment.

Aethoxysklerol may interact with other medications or substances, so it is important to discuss all current treatments with a healthcare provider. Alcohol and certain medications can affect the body's response to Aethoxysklerol, so caution is advised.